Morphological, immunohistological and clinical findings in renal amyloidosis: correlations with prognosis in 16 patients. 1979

M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso

Sixteen patients affected by renal amyloidosis (A.) and submitted to renal biopsy have been studied by light microscopy and immunofluorescence. Clinical manifestations at observation and follow up have been reviewed. Survival was 32% at ten years, lower than all other nephropathies except rapidly-progressive glomerulonephritis. Primary A. had a significantly worse survival rate than secondary A. An observation up to 6 years after biopsy allowed us to isolate a group of patients with a steady good renal function: this group is characterized by: a longer mean duration of nephropathy before observation, a lower incidence of nephrotic syndrome (NS), absence of renal failure at time of biopsy, a higher incidence of increased mesangial areas at light microscopy, a lower percentage of glomerular capillary walls thickening, a higher incidence of amyloid deposits on vessels but not on glomerular capillaries, a definite more elevated presence of Ig and C3 over mesangium and glomerular capillary walls. The possible role of the last findings is discussed.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
October 2017, Bulletin of experimental biology and medicine,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1996, Medicinski arhiv,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1975, Virchows Archiv. A, Pathological anatomy and histology,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1989, Applied pathology,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 2009, Renal failure,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
August 1978, Virchows Archiv. A, Pathological anatomy and histology,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1977, Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
December 1980, Clinical nephrology,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1961, Polskie Archiwum Medycyny Wewnetrznej,
M Surian, and L Broggi, and L Ferrari, and R Confalonieri, and S Bertoli, and G Busnach, and A Antonacci, and G Barbiano Di Belgiojoso
January 1995, Abdominal imaging,
Copied contents to your clipboard!